Revolution Medicines, Inc. · NASDAQ:RVMD
Sandler Alan B. sold 341 Revolution Medicines, Inc. shares (Form 4)
Traded Sep 16, 2026 · Filed Sep 18, 2026
On Sep 16, 2026, Sandler Alan B. (Chief Development Officer) sold 341 Revolution Medicines, Inc. shares at an average US$199.24 for US$67,940 under a trading plan, leaving 52,868 shares. Filed Sep 18, 2026 (Form 4).
- Sold
- 341 shares
- Price
- US$199.24 average (US$194.96 to US$199.30)
- Value
- US$67,940
- Holding after
- 52,868 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Common Stock | Sale | 5 | US$194.96 | 53,204 | Direct |
| Sep 16, 2026 | Common Stock | Sale | 336 | US$199.30 | 52,868 | Direct |
Source
Related
- Revolution Medicines, Inc.
- Sandler Alan B.
- Revolution Medicines, Inc. shareholders
- Form 4 · Sandler Alan B. · Oct 1, 2026
- Form 4 · Cislini Jeff · Sep 29, 2026
- Form 4 · Mancini Anthony · Sep 28, 2026
- Form 4 · Anderson Elizabeth M · Sep 24, 2026
- Form 4 · Mancini Anthony · Sep 22, 2026
- Form 4 · Anders Jack · Sep 18, 2026